GMRE:NYE-Global Medical REIT Inc (USD)

COMMON STOCK | REIT - Healthcare Facilities |

Last Closing

USD 8.89

Change

+0.10 (+1.14)%

Market Cap

N/A

Volume

0.50M

Analyst Target

USD 14.79
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-13 )

Largest Industry Peers for REIT - Healthcare Facilities

Symbol Name Price(Change) Market Cap
WELL Welltower Inc

-1.01 (-0.74%)

USD 84.14B
VTR Ventas Inc

-0.03 (-0.05%)

USD 27.32B
DOC Healthpeak Properties Inc

-0.14 (-0.64%)

USD 15.92B
CTRE CareTrust REIT Inc.

-0.40 (-1.30%)

USD 5.63B
AHR American Healthcare REIT, Inc.

+0.89 (+3.43%)

USD 4.05B
NHI National Health Investors Inc

-2.06 (-2.57%)

USD 3.69B
LTC LTC Properties Inc

-0.73 (-1.86%)

USD 1.71B
UHT Universal Health Realty Income..

-1.40 (-3.27%)

USD 0.56B
CHCT Community Healthcare Trust Inc

-0.08 (-0.42%)

USD 0.53B
GMRE-PA Global Medical REIT Inc

-0.02 (-0.06%)

USD 0.41B

ETFs Containing GMRE

KBWY Invesco KBW Premium Yield.. 0.00 % 0.35 %

-0.09 (0%)

USD 0.25B
SDEF 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (REIT - Healthcare Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -19.91% 14% F 10% F
Dividend Return 5.68% 46% F 78% C+
Total Return -14.23% 14% F 12% F
Trailing 12 Months  
Capital Gain -9.01% 14% F 12% F
Dividend Return 8.60% 85% B 86% B+
Total Return -0.41% 14% F 16% F
Trailing 5 Years  
Capital Gain -31.83% 38% F 15% F
Dividend Return 31.67% 69% C- 83% B
Total Return -0.15% 38% F 24% F
Average Annual (5 Year Horizon)  
Capital Gain -3.53% 36% F 18% F
Dividend Return 3.05% 36% F 37% F
Total Return 6.58% 86% B+ 90% A-
Risk Return Profile  
Volatility (Standard Deviation) 24.86% 43% F 44% F
Risk Adjusted Return 12.28% 36% F 30% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.